Satellos Bioscience Inc. (MSCL.V) TSXV

0.56

+0.01(+1.82%)

Updated at February 14, 2024 03:08PM

Currency In CAD

Valuation

Market Cap48.5M
Enterprise Value26.43M
P/E Ratio-1.76
PEG Ratio-0.02
Price/Sales Ratio0
Price/Book Ratio0.49
Enterprise/Revenue0
Enterprise/EBITDA-5.09

Fiscal Year

Fiscal YearDecember 31, 2023
Most Recent QuarterDecember 31, 2023

Profitability

Profit Margin0
Operating Margin0

Management Effectiveness

Return On Assets-0.26
Return On Equity-0.51

Income Statement

Revenue0
Revenue/Share0
Gross Profit-336,948
EBITDA-8.07M
Net Income-11.32M
Diluted EPS-0.32

Balance Sheet

Total Cash39.59M
Total Cash/Share1.11
Total Debt0
Total Debt/Equity0
Current Ratio11.13
Book Value Per Share1.14

Price History

52-Week Change60
52-Week High0.85
52-Week Low0.29
Moving Average 50 Days0.5
Moving Average 200 Days0.47

Statistics

Average Volume75,811
Shares Outstanding112.79M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:20
Last Split DateAugust 18, 2021